News

DVT Requires Aggressive Tx To Avoid Chronic Syndrome

Publish date: November 1, 2006
PDF Download

 

If approved by NIH, ATTRACT will start in April 2007 and be led by Dr. Suresh Vedantham of Washington University, St. Louis.

Pages

Recommended Reading

Novel Antihypertensive Safe, Effective in Phase III Trial
MDedge Internal Medicine
Aliskiren's Safety Shown in Analysis of Over 7,000 Patients
MDedge Internal Medicine
BP Goals Often Unmet in Diabetic Cardiovascular Patients
MDedge Internal Medicine
Ezetimibe Gets LDL to Goal in High-Risk Patients
MDedge Internal Medicine
Eating Nuts Tied to Highly Significant Drop in CHD Death Risk
MDedge Internal Medicine
Standardization Urged in Valve Disease Guidelines
MDedge Internal Medicine
Five Types of MI Will Make Up New Definition
MDedge Internal Medicine
FDA: Ibuprofen Blocks Aspirin's Cardioprotection
MDedge Internal Medicine
Excess Deaths, MIs Seen With Drug-Eluting Stents
MDedge Internal Medicine
Revascularization Recommended for Severe Refractory Angina
MDedge Internal Medicine